Dairy products may reduce type 2 diabetes or cardiovascular disease risk

Key points
- Dairy products may reduce type 2 diabetes or cardiovascular disease risk.
- According to a recent review from Netherlands, "Diet is important in the prevention and treatment of the metabolic syndrome, a cluster of metabolic risk markers, leading to type 2 diabetes and coronary heart disease (CHD).
- Mensink and colleagues at Maastricht University explained, "Epidemiological studies suggest a beneficial relationship between the consumption of low-fat dairy products and type 2 diabetes.
- These associations, however, do not prove causality, which can only be demonstrated by intervention studies.
Dairy products may reduce type 2 diabetes or cardiovascular disease risk.
According to a recent review from Netherlands, "Diet is important in the prevention and treatment of the metabolic syndrome, a cluster of metabolic risk markers, leading to type 2 diabetes and coronary heart disease (CHD). The aim of this review is to summarize recent findings from human studies on the effects of dairy products in this area."
R.P. Mensink and colleagues at Maastricht University explained, "Epidemiological studies suggest a beneficial relationship between the consumption of low-fat dairy products and type 2 diabetes.
For CHD, relationships are less consistent. These associations, however, do not prove causality, which can only be demonstrated by intervention studies. Several intervention trials have indeed shown positive effects on metabolic risk markers, of which dairy products were a part."
The reviewers finished, "The contribution of dairy products to the effects observed, however, is not known. Another important question is if dairy products contain a bioactive component that can explain these findings. In this respect, it is not likely that effects observed can be attributed to conjugated linoleic acid (CLA)."
Mensink and colleagues published their review in International Dairy Journal (Dairy products and the risk to develop type 2 diabetes or cardiovascular disease. INT DAIRY J, 2006;16(9):1001-1004).
For additional information, contact R.P. Mensink, Maastricht University, Dept. of Human Biology, Nutrition & Toxicology Research Institute Maastricht, POB 616, NL-6200 MD Maastricht, Netherlands.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsResearchers find a potential target for the treatment of type 2 diabetes
Currently, there are more than 350 million type 2 diabetics and according to the World Health Organization (WHO) by 2030 it will be the 7th leading cause of death worldwide. The hallmark of type 2 diabetes is insulin…
19 June 2015
NewsWhich artificial pancreas system is the best for children with type 1 diabetes?
A Montréal research team, co-supervised by Dr. Rémi Rabasa-Lhoret from the IRCM and Dr. Laurent Legault from the Montreal Children's Hospital, undertook the first paediatric outpatient study to compare three alternative…
11 June 2015
NewsA step towards a type 1 diabetes vaccine by using nanotherapy
Two years ago, the Immunology of Diabetes Research Group at the Germans Trias Research Institute (at Universitat Autònoma de Barcelona - Campus of International Excellence Sphere) reported a new experimental…






